Inhibition of lipid peroxidation and oxidative DNA damage by Ganoderma lucidum

Phytotherapy Research

Volumn 15, Issue 3, 2001, Pages 245-249

  Lee, Jong Min ^a   Kwon, Hoonjeong ^a   Jeong, Hoon ^b   Lee, June Woo ^b   Lee, Seung Yong ^b   Baek, Seong Jin ^b   Surh, Young Joon ^a  

^a Seoul National University   (South Korea)

^b IlYang Central Research Institute   (South Korea)

Author keywords

Antioxidant activity; Chemoprevention; Ganoderma lucidum; Oxidative damage

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIOXIDANT; GANODERMA LUCIDUM EXTRACT; HYDROGEN PEROXIDE; PHORBOL ESTER; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN HOMOGENATE; CELL LINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA DAMAGE; DNA STRAND BREAKAGE; HUMAN; HUMAN CELL; LIPID PEROXIDATION; MALE; MEDICINAL PLANT; NONHUMAN; PROMYELOCYTIC LEUKEMIA; RADIATION INJURY; RAT; TRADITIONAL MEDICINE; ULTRAVIOLET RADIATION;

ANIMALS; ANTIOXIDANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; FREE RADICAL SCAVENGERS; HL-60 CELLS; HUMANS; LIPID PEROXIDATION; MALE; PLANTS, MEDICINAL; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES;

GANODERMA LUCIDUM;

EID: 0034998203     PISSN: 0951418X     EISSN: None     Source Type: Journal    
DOI: 10.1002/ptr.830     Document Type: Article

References (40)

1. Ames BN, Shigenaga MK, Hagen TM. 1993. Oxidants, antioxidants and degenerative diseases of aging. Proc Natl Acad Sci USA 90: 7915-7922.
2. Cerutti PA. 1989. Prooxidant states and tumor promotion. Cancer Detect Prev 14: 281-284.
3. Chang WS, Chang YH, Lu FJ, Chiang HC. 1994. Inhibitory effects of phenolics on xanthine oxidase. Anticancer Res 14: 501-506.
4. Chen WC, Hau DA, Lee SS. 1995. Effect of Ganoderma lucidum and Krestin on cellular immuno competence in gamma-ray-irradiated mice. Am J Chin Med 23: 71-80.
5. Cheng HH, Hsieh KH, Tung YC, Tung TC. 1988. Effect of Ganoderma lucidum extract on interleukin-2 production in mice. J Chin Oncol Soc 4: 73-82.
6. Cheng HH, Tung YC, Tung TC. 1985. The antitumor effect of cultivated Ganoderma lucidum extract. III. Effect of Ganoderma lucidum extract on human T cell subsets. J Chin Oncol Soc 1: 147-156.
7. Hikino HH, Ishiyama M, Suzuki Y, Konno C. 1989. Mechanisms of hypoglycemic activity of Ganoderma B: a glycan of Ganoderma lucidum fruit bodies. Planta Med 55: 423-428.
8. Hsu HY, Lian SL, Lin CC. 1990. Radioprotective effect of Ganoderma lucidum (Ley ss. ex. fr.) Karst after x-ray irradiation in mice. Am J Chin Med 18: 61-69.
9. Kabir Y, Kimura S, Tamura T. 1988. Dietary effect of Ganoderma lucidum mushroom on blood glucose levels in spontaneously hypertensive rats. J Nutr Sci Vitaminol 34: 433-438.
10. Kim RS, Kim HW, Kim BK. 1997. Suppressive effects of Ganoderma lucidum on proliferation of peripheral blood mononuclear cells. Mol Cells 7: 52-57.
11. Kimura Y, Okuda H, Arichi S. 1988. Effects of the extracts of Ganoderma lucidum on blood glucose level in rats. Planta Med 54: 290-294.
12. Klaunig JE, Xu Y, Isenberg JS et al. 1998. The role of oxidative stress in chemical carcinogenesis. Environ Health Perspect 106 (suppl. 1); 289-295.
13. Komoda Y, Shimizu M, Sonoda Y, Sato Y. 1989. Ganoderic acid and its derivatives as cholesterol synthesis inhibitors. Chem Pharm Bull 37: 531-533.
14. Koyama K, Imaizumi T, Akiba M et al. 1997. Antinociceptive components of Ganoderma lucidum. Planta Med. 63: 224-227.
15. Kozumbo WJ, Trush MA, Kensler TW. 1985. Are free radicals involved in tumor promotion? Chem Biol Interact 54: 199-207.
16. Lee EB, Cheon SA, Kim SM et al. 1994b. General pharmacology of G009, a polysaccharide isolated from Ganoderma lucidum IY 009. J Appl Pharmacol (Korean) 2: 369-375.
17. Lee JY, Park KS, Chung JH et al. 1994a. Effects of G009 on chemical-induced liver damage in rats. J Appl Pharmacol (Korean), 2: 206-212.
18. Lee E, Park K-K, Lee J-M et al. 1998a. Suppression of mouse skin tumor promotion and induction of apoptosis in HL-60 cells by Alpinia oxyphylla Miquel (Zingiberaceae). Carcinogenesis 19: 1377-1381.
19. Lee S, Park S, Oh JW, Yang C. 1998b. Natural inhibitors of protein phenyltransferase. Planta Medica 64: 303-308.
20. Lee SY, Rhee HM. 1990. Cardiovascular effects of mycelium extract of Ganoderma lucidum: inhibition of sympathetic outflow as a mechanism of its hypotensive action. Chem Pharm Bull 38: 1359-1364.
21. Lieu C-W, Lee S-S, Wang SY. 1992. The effect of Ganoderma lucidum on induction of differentiation in leukemic U937 cells. Anticancer Res 12: 1211-1216.
22. Lin CN, Tome WP, Won SJ. 1991. Novel cytotoxic principles of Formasan Ganoderma lucidum. J Nat Prod 54: 998-1002.
23. Lin J-M, Chen C-C, M F, Ujiie T, Takada A. 1995. Radical scavenger and antihepatotoxic activity of Ganoderma formosanum, Ganoderma lucidum and Ganoderma neojaponicum. J Ethnopharmacol 41: 33-41.
24. Lin J-M, Lin C-C, Chiu H-F, Yang J-J, Lee S-G. 1993. Evaluation of the anti-inflammatory and liver-protective effects of Anoectochilus formosanus, Ganoderma lucidum and Gynostemma pentaphyllum in rats. Am J Chin Med 21: 59-69.
25. Maruyama H, Yamazaki K, Murofushi S, Konda C, Ikekawa T. 1989. Antitumor activity of Sarcodon aspratus (Berk.) S. Ito and Ganoderma lucidum (Fr.) Karst. J Phamacobio Dyn-12: 118-123.
26. Miyazaki T, Nishijima M. 1981. Studies on fungal polysaccharides. XXVII. Structural examination of a water-soluble antitumor polysaccharide of Ganoderma lucidum. Chem Pharm Bull 29: 3611-3616.
27. Murasugi A, Tanaka S, Komiyama N et al 1991. Molecular cloning of a cDNA and a gene encoding an immuno-modulatory protein, Ling Zhi-8, from a fungus, Ganoderma lucidum. J Biol Chem 266: 2486-2493.
28. Park EJ, Ko G, Kim J, Sohn DH. 1997. Antifibrotic effects of a polysaccharide extracted from Ganoderma lucidum, glycyrrhizin and pentoxyfyllin in rats with cirrhosis induced by biliary obstruction. Biol Pharm Bull 20: 417-420.
29. Park MK, Park JH, Lee MY, Park IJ, Kim SU, Lee SY, Jeong H. 1994. Physicochemical properties of G009. J Appl Pharmacol 2: 244-246.
30. Pincemail JJ. 1995. Free radicals and antioxidants in human diseases. In Analysis of Free Radicals in Biological Systems, Favier AE, Cadet J, Kalyanaraman B, Fontecave M, Pierre J-L (eds). Birkhauser Verlag: Berlin; 83-98.
31. Prasad K, Laxdal VA. 1994. Evaluation of hydroxyl radical-scavenging property of purpurogallin using high pressure liquid chromatography. Mol Cell Biochem 135: 153-158.
32. Shimizu A, Yano T, Saito Y, Inada Y. 1985. Isolation of an inhibitor of platelet aggregation from a fungus, Ganoderma lucidum. Chem Pharm Bull 33: 3012-3015.
33. Sone Y, Okuda R, Wada N, Kishida E, Misaki A. 1985. Structures and antitumor activities of the polysaccharides isolated from fruiting body and the growing culture of mycelium of Ganoderma lucidum. Agric Biol Chem 49: 2641-2653.
34. Sreejayan, Rao MNA. 1994. Curcuminoids as potent inhibitors of lipid peroxidation. J Pharm Pharmacol 46: 1013-1016.
35. Stabric B. 1993. Antimutagens and anticarcinogens in foods. Food Chem Toxicol 32: 79-90.
36. Tao J, Peng KY. 1990. Experimental and clinical studies on inhibitory effect of Ganoderma lucidum on platelet aggregation. J Tongi Med Univ 10: 240-243.
37. Van der Hem LG, Van der Vliet JA, Bocken CF, Kino K, Hoitsma AJ, Tax WJ. 1995. Ling Zhi-8: studies of a new immunomodulating agent. Transplantation 60: 438-443.
38. Wang JF, Zang JJ, Chen WW. 1985. Study of the action of Ganoderma lucidum on scavenging hydroxyl radicals from plasma. J Trad Chin Med 5: 55-60.
39. Wang S-Y, Hsu M-L, Hsu H-C et al. 1997. The antitumor effects of Ganoderma lucidum is mediated by cytokines released from activated macrophages and T lymphocytes. Int J Cancer 70: 699-705.
40. Yun TK, Kim SH, Lee YS. 1995. Trial of a new medium-term model using benzo(a)pyrene induced lung tumor in newborn mice. Anticancer Res 15: 839-845.